iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes: a Pilot Randomized, Controlled Trial
The University of Texas Health Science Center, Houston
200 participants
Nov 12, 2019
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT
Eligibility
Inclusion Criteria3
- All patients >/= women 18 years of age with gestational diabetes or type 2 diabetes during pregnancy and identified by the research team and consented before 30.6 weeks.
- Non-anomalous singletons
- Ability to provide informed consent
Exclusion Criteria3
- Patients with Type 1 diabetes
- Patients with fetal major congenital abnormalities
- Patients identified/referred after 30.6 weeks
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Subjects will have routine care enhanced by use of theThe iGlucose Smart meter system. This is an example of integration of a SMBG system with internet-based technology; including cell phone notifications for reminders, feedback, and communication with clinicians
Subjects will receive routine care with the insurance prescribed glucose meter. They will self manage with traditional diabetes diary.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04206748